Search results
Results from the WOW.Com Content Network
Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, [1] develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose®.
An Internet forum, or message board, is an online discussion site where people can hold conversations in the form of posted messages. [1] They are an element of social media technologies which take on many different forms including blogs, business networks, enterprise social networks, forums, microblogs, photo sharing, products/services review, social bookmarking, social gaming, social ...
In 2001 the company acquired Biochem Canada. [9] Shire's next acquisition didn't come until 2005 when it acquired Transkaryotic Therapeutics [10] and two years later – in 2007 – New River Pharmaceuticals Inc, for a then company record of $2.6 billion. [11]
Forum spam consists of posts on Internet forums that contains related or unrelated advertisements, links to malicious websites, trolling and abusive or otherwise unwanted information. Forum spam is usually posted onto message boards by automated spambots or manually with unscrupulous intentions with intent to get the spam in front of readers ...
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary ...
Janssen (Leiden, 2021) The early roots of what would become Janssen Pharmaceuticals date back to 1933. In 1933, Constant Janssen, the father of Paul Janssen, acquired the right to distribute the pharmaceutical products of Richter, a Hungarian pharmaceutical company, for Belgium, the Netherlands and Belgian Congo.
Melinta Therapeutics, founded in 2000 as Rib-X Pharmaceuticals, is an American publicly traded biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital settings.
Salix was founded in 1989 [1] in Sunnyvale, California by Randy W. Hamilton and Lorin K. Johnson.. From 1992 to 2001, the company was headquartered in Palo Alto before relocating to its current headquartered in Raleigh.